M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Mirum Pharmaceuticals, Inc. to acquire Bluejay Therapeutics
Announced Dec 8, 2025 · Closed Jan 26, 2026 · Private target
Deal value$620M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- Mirum Pharmaceuticals, Inc. (MIRM)
- Target
- Bluejay Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 26, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Morgan Stanley
- To the target
- Centerview
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations